Abstract
We present the case of a 55-year-old male patient who presented with palpable cervical lymphadenopathy. Excisional biopsy showed metastatic adenocarcinoma of unknown origin. Imaging showed a bladder mass following which he underwent transurethral resection of bladder tumour. Histopathological evaluation of mass confirmed a poorly differentiated adenocarcinoma with signet-ring cell features. Immunohistochemistry was suggestive of metastatic urachal cancer. He agreed for enrollment in a clinical trial, however soon after 1st cycle, he developed immune pneumonitis requiring high dose steroids. On follow-up, MRI brain was done for evaluation of headache which showed metastatic intracranial disease. He completed radiotherapy following which he was started on FOLFOX chemo regimen (folinic acid, 5-fluorouracil and oxaliplatin).
Keywords:
cancer intervention; malignant disease and immunosuppression; radiology (diagnostics).
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.
MeSH terms
-
Adenocarcinoma* / immunology
-
Adenocarcinoma* / pathology
-
Adenocarcinoma* / therapy
-
Antineoplastic Combined Chemotherapy Protocols* / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols* / adverse effects
-
Biopsy / methods
-
Brain Neoplasms* / diagnostic imaging
-
Brain Neoplasms* / pathology
-
Brain Neoplasms* / secondary
-
Diagnosis, Differential
-
Fluorouracil / administration & dosage
-
Fluorouracil / adverse effects
-
Humans
-
Immunohistochemistry
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Leucovorin / administration & dosage
-
Leucovorin / adverse effects
-
Lymph Nodes / pathology*
-
Lymphatic Metastasis* / pathology
-
Lymphatic Metastasis* / therapy
-
Magnetic Resonance Imaging / methods
-
Male
-
Middle Aged
-
Neck
-
Neoplasm Staging
-
Organoplatinum Compounds / administration & dosage
-
Organoplatinum Compounds / adverse effects
-
Radiotherapy / methods*
-
Urinary Bladder Neoplasms* / immunology
-
Urinary Bladder Neoplasms* / pathology
-
Urinary Bladder Neoplasms* / therapy
Substances
-
Immunosuppressive Agents
-
Organoplatinum Compounds
-
Leucovorin
-
Fluorouracil
Supplementary concepts
-
Folfox protocol
-
Urachal cancer